# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 4...
Stifel analyst Thomas Stephan maintains Iridex (NASDAQ:IRIX) with a Hold and maintains $2 price target.
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 7...
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.05) by 2...
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...